News tagged with lung cancer
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth
(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, ...
Nanotechnology / Bio & Medicine
Apr 06, 2012 |
5 / 5 (8) |
1
|
Plasmonic nanocrosses that heat up when illuminated can be used to kill cancer
Plasmonic nanoparticles are extremely sensitive to light, and even the tiniest amount can cause these particles to heat up. Scientists are now trying to use plasmonic nanoparticles in cancer therapy whereby ...
Nanotechnology / Bio & Medicine
Dec 23, 2011 |
5 / 5 (5) |
0
Researchers unveil new method for detecting lung cancer
When lung cancer strikes, it often spreads silently into more advanced stages before being detected. In a new article published in Nature Nanotechnology, biological engineers and medical scientists at the ...
Nanotechnology / Bio & Medicine
Sep 15, 2011 |
4.8 / 5 (4) |
1
|
Inhaled nanoparticles deliver potent anticancer cocktail to lung tumors and block resistance
(PhysOrg.com) -- An ideal treatment for lung cancer would be one that could be inhaled deep into lung tissue where it would deliver tumor-killing agents that would then largely stay in the lungs, avoiding the toxicities that ...
Nanotechnology / Bio & Medicine
Nov 21, 2011 |
4.8 / 5 (4) |
0
|
UK taxi driver becomes first mummy for 3,000 years
A former British taxi driver has become the first person in the world for 3,000 years to be mummified in the same way as the pharaohs.
Other Sciences / Archaeology & Fossils
Oct 18, 2011 |
3 / 5 (5) |
11
Protein KO stops tumour growth
(PhysOrg.com) -- Research published last week in the journal PNAS may have identified a promising new target for developing drugs against one of the most common types of lung cancer.
Apr 19, 2011 |
5 / 5 (2) |
0
|
New device uses gold nanoparticles to test for lung cancer
The metabolism of lung cancer patients is different than the metabolism of healthy people. And so the molecules that make up cancer patients' exhaled breath are different too. A new device pioneered at the University of Colorado ...
Nanotechnology / Bio & Medicine
Nov 17, 2011 |
5 / 5 (2) |
0
|
Researchers develop novel drug delivery system
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. ...
Jan 31, 2012 |
5 / 5 (2) |
0
Cancer death rate gap widens based on education
(AP) -- The gap in cancer death rates between college graduates and those who only went to high school is widening, the American Cancer Society reported Friday.
Jun 17, 2011 |
5 / 5 (1) |
0
Lung cancer scans: False alarms amid lives saved
(AP) -- Full results of a big study that showed some smokers' lives could be saved by screening with lung scans now reveal more clearly what the risks are: There's a good chance of a false alarm.
Jun 29, 2011 |
5 / 5 (1) |
0
UN: Deaths up from cancer, diabetes, heart disease
(AP) -- Nearly two-thirds of deaths in the world are caused by noncommunicable diseases such as cancer, diabetes and heart and lung disease which are rapidly increasing at a cost to the global economy of trillions of dollars, ...
Jun 21, 2011 |
4 / 5 (1) |
1
Lung cancer
Lung cancer is a disease of uncontrolled cell growth in tissues of the lung. This growth may lead to metastasis, which is the invasion of adjacent tissue and infiltration beyond the lungs. The vast majority of primary lung cancers are carcinomas of the lung, derived from epithelial cells. Lung cancer, the most common cause of cancer-related death in men and the second most common in women (after breast cancer), is responsible for 1.3 million deaths worldwide annually. The most common symptoms are shortness of breath, coughing (including coughing up blood), and weight loss.
The main types of lung cancer are small cell lung carcinoma and non-small cell lung carcinoma. This distinction is important, because the treatment varies; non-small cell lung carcinoma (NSCLC) is sometimes treated with surgery, while small cell lung carcinoma (SCLC) usually responds better to chemotherapy and radiation. The most common cause of lung cancer is long-term exposure to tobacco smoke. The occurrence of lung cancer in nonsmokers, who account for as many as 15% of cases , is often attributed to a combination of genetic factors, radon gas, asbestos, and air pollution, including secondhand smoke.
Lung cancer may be seen on chest radiograph and computed tomography (CT scan). The diagnosis is confirmed with a biopsy. This is usually performed via bronchoscopy or CT-guided biopsy. Treatment and prognosis depend upon the histological type of cancer, the stage (degree of spread), and the patient's performance status. Possible treatments include surgery, chemotherapy, and radiotherapy. With treatment, the five-year survival rate is 14%.
For more information about Lung cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.